Title | PHOTACs enable optical control of protein degradation. |
Publication Type | Journal Article |
Year of Publication | 2020 |
Authors | Reynders M, Matsuura BS, Bérouti M, Simoneschi D, Marzio A, Pagano M, Trauner D |
Journal | Sci Adv |
Volume | 6 |
Issue | 8 |
Pagination | eaay5064 |
Date Published | 2020 02 |
ISSN | 2375-2548 |
Keywords | Cell Line, Tumor, Humans, Light, Optical Phenomena, Proteolysis, Tacrolimus Binding Protein 1A |
Abstract | PROTACs (PROteolysis TArgeting Chimeras) are bifunctional molecules that target proteins for ubiquitylation by an E3 ligase complex and subsequent degradation by the proteasome. They have emerged as powerful tools to control the levels of specific cellular proteins. We now introduce photoswitchable PROTACs that can be activated with the spatiotemporal precision that light provides. These trifunctional molecules, which we named PHOTACs (PHOtochemically TArgeting Chimeras), consist of a ligand for an E3 ligase, a photoswitch, and a ligand for a protein of interest. We demonstrate this concept by using PHOTACs that target either BET family proteins (BRD2,3,4) or FKBP12. Our lead compounds display little or no activity in the dark but can be reversibly activated with different wavelengths of light. Our modular approach provides a method for the optical control of protein levels with photopharmacology and could lead to new types of precision therapeutics that avoid undesired systemic toxicity. |
DOI | 10.1126/sciadv.aay5064 |
Alternate Journal | Sci Adv |
PubMed ID | 32128406 |
PubMed Central ID | PMC7034999 |
Grant List | R01 CA076584 / CA / NCI NIH HHS / United States S10 OD016343 / OD / NIH HHS / United States T32 CA009161 / CA / NCI NIH HHS / United States / HHMI / Howard Hughes Medical Institute / United States |
Related Lab:
Related Faculty:
Antonio Marzio, Ph.D.